Dividend
-
-
-
-
-
-
-
Quidel Receives Emergency Use Authorization for QuickVue® SARS Rapid Antigen Test for COVID-19 Diagnosis
-
-
-
-
-
-
-
Quidel Corporation Statement on President Trump’s Announcement of Coronavirus Testing Strategy
-
-
-
-
-
-
-
Quidel Corp (QDEL) Announces Health Canada Approval for Lyra Direct SARS-CoV-2 Assay
-
-
-
-
-
-
-
Quidel Corp (QDEL) Prelim. Q2 Revenue Tops Consensus
-
-
-
-
-
-
-
Quidel Receives Amended Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay Using Sofia 1 Instrument
-
-
-
-
-
-
-
Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay
-
-
-
-
-
-
-
Quidel Reports First Quarter 2019 Financial Results
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

